Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,174.2
14.4 (0.46%)

 

  • STI Straits Times Index
    3,174.2
    14.4 (0.46%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,563.6
    2.6 (0.17%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,217.0
    154.5 (0.59%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,899.5
    21.4 (0.74%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,300.1
    164.9 (0.71%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,152.1
    39.2 (0.64%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,060.7
    -8.2 (-0.39%)
    Index delayed 20 minutes
  • XAO XAO
    6,791.1
    76.7 (1.14%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 835.5M
  • Value: 956.9M
  • Rise: 173
  • Fall: 112
  • Unch: 542

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Golden Agri-Res0.230+0.015
Rex Intl0.174+0.002
Tritech0.026-0.002
YZJ Shipbldg SGD1.100+0.030
Mapletree NAC Tr1.150-0.010
MDR0.001-
AusGroup^0.030+0.002
UMS0.990+0.040
ComfortDelGro2.400+0.060
Keppel Reit1.250+0.010

World Indices

World Indices
Name Last Change
Nasdaq 8,566.7 +46.0
HSI 26,217.0 +154.5
HSCEI 10,321.8 +67.7
Jakarta 6,152.1 +39.2
Nikkei 225 23,300.1 +164.9
SSE Comp 2,899.5 +21.4
Shanghai A 3,038.2 +22.3
Shanghai B 241.6 +4.0
PSE Comp 0.0
KOSPI 2,060.7 -8.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AMARIN CORP ADR EACH REP 1 ORD GBP0.50 AMARIN CORPORATION PLC SPONSORED ADR
Updated on 04 Dec 2019 (End of trading day)
Last (USD): 22.780 Change: +1.150 High: 22.980 Remarks: -
Change (%): +5.32 Low: 21.650
Open 21.850 Yesterday's Close 21.630000000000003
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 10,973,090 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.32389 Trailing EPS (USD) e -0.23516 NAV (USD) b 0.3545
PE a - Trailing PE f - Price / NAV b 64.2595
Dividend (USD) d - Cash In Hand (USD) g 0.6221 Issued & Paid-up Shares c 358,907,000
Dividend Yield (%) d - Price / Cash In Hand g 36.618 Treasury Shares h 3,841,615
Beta - 75 Daysi 0.384 R-Squared - 75 Days(%)i 0.14 Market Cap (M) 8,175.901
Beta - 500 Daysi -0.075 R-Squared - 500 Days (%)i - Enterprise Value (M) 8,051.249
Piotroski F Score 4 Exchange Code AMRN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 71.50 Free Float (%) 97.9
Sector & Industry Health Technology - Pharmaceuticals: Other
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Aug 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AMARIN CORP ADR EACH REP 1 ORD GBP0.50 NASDAQ 8,175.901 - - 64.2595 -
Industry Pharmaceuticals: Other NASDAQ 1,238.698 28.845 295.091 5.9542 -
Local Peer ICON PLC NASDAQ 8,735.437 27.074 24.055 5.8147 -
Local Peer JAZZ PHARMACEUTICALS PLC NASDAQ 8,381.856 18.747 13.767 2.7442 -
Local Peer SAGE THERAPEUTICS INC NASDAQ 7,731.764 - - 7.1520 -
Local Peer MEDICINES CO NASDAQ 6,719.984 - - -112.8608 -
Local Peer ARGENX SE SPON ADR EACH REP 1 ORD SHS NASDAQ 6,448.405 - - 8.5099 -
Local Peer HORIZON THERAPEUTICS PLC NASDAQ 6,109.791 - 90.103 3.9277 -
Local Peer UNITED THERAPEUTICS CORP NASDAQ 4,008.091 6.803 - 1.4758 -
Local Peer INTERCEPT PHARMACEUTICALS INC NASDAQ 3,850.710 - - 29.4542 -
Local Peer GW PHARMACEUTICALS ADS EA REPR 12 ORD GBP0.00 NASDAQ 3,253.428 - - 4.5208 -
Local Peer MYOKARDIA INC NASDAQ 3,101.302 - - 6.8559 -
Local Peer PORTOLA PHARMACEUTICALS INC NASDAQ 2,163.250 - - 10.1614 -
Local Peer ZOGENIX INC NASDAQ 2,070.691 - - 8.2631 -
Other Local Peers PACIRA BIOSCIENCES INC (NASDAQ), IRONWOOD PHARMACEUTICALS INC (NASDAQ), MADRIGAL PHARMACEUTICALS INC (NASDAQ), AXSOME THERAPEUTICS INC (NASDAQ), CORCEPT THERAPEUTICS INC (NASDAQ), INNOVIVA INC (NASDAQ), ENDO INTERNATIONAL PLC (NASDAQ), THERAVANCE BIOPHARMA INC (NASDAQ), SUPERNUS PHARMACEUTICALS INC (NASDAQ), ARQULE INC (NASDAQ), AERIE PHARMACEUTICALS INC (NASDAQ), AMPHASTAR PHARMACEUTICALS INC (NASDAQ), EAGLE PHARMACEUTICALS INC (NASDAQ), ANIKA THERAPEUTICS INC (NASDAQ), REVANCE THERAPEUTICS INC (NASDAQ), ANI PHARMACEUTICALS INC (NASDAQ), COLLEGIUM PHARMACEUTICAL INC (NASDAQ), INTERSECT ENT INC (NASDAQ), BIODELIVERY SCIENCES INTERNATIONAL (NASDAQ), CATALYST PHARMACEUTICALS INC (NASDAQ), ASSEMBLY BIOSCIENCES INC (NASDAQ), DURECT CORP (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), ALBIREO PHARMA INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), FOAMIX PHARMACEUTICALS LTD (NASDAQ), ADAMAS PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), HARROW HEALTH INC (NASDAQ), ACASTI PHARMA INC (NASDAQ), CERECOR INC (NASDAQ), MEI PHARMA INC (NASDAQ), ACELRX PHARMACEUTICALS INC (NASDAQ), GALMED PHARMACEUTICALS LTD (NASDAQ), ZYNERBA PHARMACEUTICALS INC (NASDAQ), HAPPINESS BIOTECH GROUP LTD (NASDAQ), AGILE THERAPEUTICS INC (NASDAQ), ORAMED PHARMACEUTICALS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), NEOS THERAPEUTICS INC (NASDAQ), CUMBERLAND PHARMACEUTICALS INC (NASDAQ), ACLARIS THERAPEUTICS INC (NASDAQ), MY SIZE INC (NASDAQ), MARINUS PHARMACEUTICALS INC (NASDAQ), SCYNEXIS INC (NASDAQ), CTI BIOPHARMA CORP (NASDAQ), VERONA PHARMA SPON ADR EACH REP 8 ORD SHS (NASDAQ), PLX PHARMA INC (NASDAQ), EVOKE PHARMA INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), CASSAVA SCIENCES INC (NASDAQ), VIVUS INC (NASDAQ), BIOLINE RX LTD SPON ADS EACH REPR 15 ORD SHS (NASDAQ), EYEGATE PHARMACEUTICALS INC (NASDAQ), MELINTA THERAPEUTICS INC (NASDAQ), INTEC PHARMA LTD (NASDAQ), HEPION PHARMACEUTICALS INC (NASDAQ), REGULUS THERAPEUTICS INC (NASDAQ), LIPOCINE INC (NASDAQ), KEMPHARM INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), TETRAPHASE PHARMACEUTICALS INC (NASDAQ), SONOMA PHARMACEUTICALS INC (NASDAQ), RITTER PHARMACEUTICALS INC (NASDAQ), TONIX PHARMACEUTICALS HLDG CORP (NASDAQ)
Global Peer BAUSCH HEALTH COMPANIES INC NYSE 10,107.721 - - 4.0724 -
Global Peer CATALENT INC NYSE 7,575.880 57.393 54.739 4.5934 -
Global Peer FOSUN PHARMA HKEx 56,255.677 17.539 18.373 1.7215 1.640
Global Peer PERRIGO COMPANY PLC NYSE 6,899.416 52.667 27.990 1.1981 1.497
Global Peer Kalbe Farma Tbk. IDX 73,359,531.500 29.856 28.565 4.7876 1.661
Global Peer SH PHARMA HKEx 40,016.669 8.705 8.403 0.8776 3.315
Global Peer LIVZON PHARMA HKEx 20,891.931 16.299 15.463 1.7517 4.699
Global Peer LUYE PHARMA HKEx 20,810.565 13.480 12.016 2.1797 1.786
Global Peer HEC PHARM HKEx 18,225.743 16.326 12.389 3.9443 2.820
Global Peer PRESTIGE CONSUMER HEALTHCARE INC NYSE 1,913.877 - - 1.7199 -
Other Global Peers C ANIMAL HEALTH (HKEx), APHRIA INC (NYSE), TONG REN TANG (HKEx), SIHUAN PHARM (HKEx), BLACKMORES LTD (ASX), CLINUVEL PHARMACEUTICALS LTD (ASX), MEGA (SET), BELLRING BRANDS INC (NYSE), Kimia Farma (Persero) Tbk. (IDX), Tianjin ZX USD (SGX), FUDANZHANGJIANG (HKEx), OPTHEA LIMITED (ASX), HUA HAN HEALTH (HKEx), CONSUN PHARMA (HKEx), Tempo Scan Pacific Tbk. (IDX), MALLINCKRODT PLC (NYSE), SHANDONG XINHUA (HKEx), Indofarma (Persero) Tbk. (IDX), OCI INTL (HKEx), GOLDEN THROAT (HKEx), DOD (SET), IX Biopharma (SGX), YSPSAH (Bursa), LONGRUN TEA (HKEx), JILIN CHANGLONG (HKEx), PHARMAXIS (ASX), BOTANIX PHARMACEUTICALS LTD (ASX), ALTHEA GROUP HOLDINGS LTD (ASX), INVION LTD (ASX), TIANDA PHARMA (HKEx), LANSEN PHARMA (HKEx), COGSTATE (ASX), AMPIO PHARMACEUTICALS INC (NYSE American), SANAI HEALTH GP (HKEx), EAGLE HEALTH HOLDINGS LTD (ASX), VITA LIFE SCIENCES LIMITED (ASX), ANTISENSE THERAPEUTICS (ASX), IDT AUSTRALIA LIMITED (ASX), ACRUX (ASX), CRONOS AUSTRALIA LIMITED (ASX), PHARMAUST LIMITED (ASX), BAYTACARE PHARM (HKEx), C HEALTH GP (HKEx), CANNPAL ANIMAL THERAPEUTICS LTD (ASX), Pyridam Farma Tbk (IDX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+2.280
+11.12 %
10 Days -+2.260
+11.01 %
20 Days -+6.020
+35.92 %
Medium Term Return 3 Months -+6.780
+42.38 %
6 Months -+5.020
+28.27 %
1 Year -+4.790
+26.63 %
Long Term Return 2 Years -+19.520
+598.77 %
3 Years -+19.520
+598.77 %
5 Years -+21.740
+2090.38 %
Annualised Return Annualised --
+85.40 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 11.780 - 24.670 Change From 1 Year Low +11.000 % Change From 1 Year Low (%) +93.38
Change From 1 Year High -1.890 % Change From 1 Year High (%) -7.66
2 Years Range 2.350 - 24.670 Change From 2 Years Low +20.430 % Change From 2 Years Low (%) +869.36
Change From 2 Years High -1.890 % Change From 2 Years High (%) -7.66
5 Years Range 0.931 - 24.670 Change From 5 Years Low +21.849 % Change From 5 Years Low (%) +2346.83
Change From 5 Years High -1.890 % Change From 5 Years High (%) -7.66
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Historical Price Data

Date Open High Low Close Volume VWAP
04 Dec 2019 21.850 22.980 21.650 22.780 10,973,090 -
03 Dec 2019 21.090 21.830 20.870 21.630 5,453,327 -
02 Dec 2019 21.490 21.710 21.110 21.400 6,074,999 -
29 Nov 2019 20.650 21.346 20.600 21.270 5,100,169 -
27 Nov 2019 20.500 20.730 20.130 20.500 5,013,884 -
26 Nov 2019 21.200 21.220 20.100 20.470 6,954,322 -
25 Nov 2019 21.110 21.770 21.010 21.090 9,103,116 -
22 Nov 2019 20.700 21.100 20.245 20.910 6,081,213 -
21 Nov 2019 20.080 21.100 19.610 20.520 8,187,821 -
20 Nov 2019 21.360 22.060 19.100 20.260 32,250,970 -
19 Nov 2019 22.580 23.250 22.360 22.730 10,553,940 -
18 Nov 2019 24.110 24.200 22.250 22.600 33,200,730 -
15 Nov 2019 23.250 24.670 21.750 24.020 49,187,410 -
14 Nov 2019 21.460 22.050 20.540 21.490 23,982,450 -
13 Nov 2019 21.460 22.050 20.540 21.490 23,982,450 -
12 Nov 2019 19.480 20.960 18.920 20.940 48,075,640 -
11 Nov 2019 17.740 18.000 16.700 16.910 10,514,810 -
08 Nov 2019 16.700 17.540 16.650 17.480 8,061,764 -
07 Nov 2019 17.650 17.720 16.530 16.760 7,716,994 -
06 Nov 2019 17.350 17.930 17.300 17.480 7,753,174 -
05 Nov 2019 17.975 18.030 16.350 17.330 15,742,470 -
04 Nov 2019 17.150 17.480 16.945 17.450 7,186,044 -
Summary
Current 2 Weeks
(20 Nov 2019 to 04 Dec 2019)
21.360 22.980 19.100 22.780 95,192,911 -
Previous 2 Weeks
(06 Nov 2019 to 19 Nov 2019)
17.350 22.980 17.300 22.730 223,029,362 -
4 Weeks from
(09 Oct 2019 to 05 Nov 2019)
14.150 22.980 13.880 17.330 104,891,557 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.